| Name |
Xyzal 0,5 mg/ml oralna otopina |
| Marketing Authorisation Number |
HR-H-045076955 |
| Active Substance |
levocetirizindiklorid |
| Composition |
1 ml oralne otopine sadrži 0,5 mg levocetirizindiklorida |
| Pharmaceutical Form |
oralna otopina |
| Manufacturer |
Aesica Pharmaceuticals S.r.I., Pianezza (Torino), Italija |
| Marketing Authorisation Holder |
UCB Pharma S.A., Allée de la Recherche 60, Anderlecht (Bruxelles), Belgija |
| Marketing Authorisation Date |
23.01.2018 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/16-02/549 |
| Registration Number |
381-12-01/30-18-06 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
R06AE09 |
| Marketing status |
trajni prekid opskrbe |
| SmPC |
download |
| PL |
download |
